University of Cincinnati Cancer Center experts present research at the American Society for Radiation Oncology (ASTRO) Annual Meeting Sept. 29 through Oct. 2.
Cancer Center researchers' involvement at ASTRO includes:
- Teresa Meier, MD, moderating the special session "Developmental Therapies and Quality Assurance in Early Phase Gynecologic Clinical Trials," Sept. 29 at 8 a.m.
- Vinita Takiar, MD, PhD, participating as a mentor in the session "Navigating and Maximizing the Mentor-Mentee Relationship," Sept. 29 at 3 p.m.
- Emily Daugherty, MD, comoderating the session "Exploring the Future of AI, Radiomics and Deep Learning in Radiation Oncology Research," Sept. 29 at 4:45 p.m.
- Sarah Feldkamp, MD, presenting the poster "Treatment Patterns and Outcomes in Geriatric Women with Cervical Cancer," Sept. 30 at 8 a.m.
- Anthony Mascia, PhD, presenting "Proton Flash Trials: Insights from FAST-01 and 02," Sept. 30 at 10:45 a.m.
- Morgan Bailey, MD, presenting the poster "Progesterone Contraception Is Associated with Tumor-Related Visual Impairment in Premenopausal Women with Meningioma Referred for Radiation," Sept. 30 at 10:45 a.m.
- Jonathan Sackett, MD, presenting the poster "Rapid Early Progression After Surgery for IDH-Wildtype Glioblastoma and the Importance of the Pre-Radiation Planning MRI," Sept. 30 at 10:45 a.m.
- Luke Pater, MD, presenting the invited speaker discussion "Current Radiotherapy Approaches for Pediatric Wilms Tumor," Sept. 30 at 3 p.m.
- Julianna Korns, BS, presenting the poster "Combining Plk1 Inhibition and Radiation to Target Head and Neck Cancer," Sept. 30 at 5 p.m.
- Takiar moderating the education session "Prophylactic Feeding Tube Placement in Head and Neck Cancer: Hard to Swallow?" Oct. 1 at 2:30 p.m.
- Maddie Schumacher, BS, presenting the poster "Toxicity After Proton Beam Therapy for New and Recurrent Breast Cancer," Oct. 2 at 8:30 a.m.
- Alyssa Farley, MD, presenting the poster "Osteoradionecrosis Incidence in Oral Cavity Squamous Cell Carcinoma," Oct. 2 at 10:30 a.m.
Featured photo at top of meningioma cells. Photo/OGphoto/iStock.
/University Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
